Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia
1998

Erythropoietin Treatment Increases Tumor Radiosensitivity in Anemic Rats

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): 0 Thews, R Koenig, DK Kelleher, J Kutzner, P Vaupel

Primary Institution: Johannes Gutenberg-University

Hypothesis

Does erythropoietin treatment improve the radiosensitivity of tumors in chemotherapy-induced anemic rats?

Conclusion

Erythropoietin treatment significantly increases the radiosensitivity of solid tumors in anemic rats.

Supporting Evidence

  • Erythropoietin treatment resulted in a higher mean hemoglobin concentration compared to the control group.
  • Rats treated with erythropoietin showed a longer growth delay of tumors after radiation.
  • Significant differences in tumor regrowth rates were observed between the anemic and non-anemic groups.

Takeaway

Giving a medicine called erythropoietin to rats with anemia helps their tumors respond better to radiation treatment.

Methodology

Male Sprague-Dawley rats were treated with carboplatin to induce anemia and then with erythropoietin before irradiating the tumors.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Male Sprague-Dawley rats, body weight 140-170 g.

Statistical Information

P-Value

0.0017

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication